Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in cancer patients may vary widely dependent on the geographic area and this has significant implications for oncological care. The aim of this observational, prospective study was to assess the seroprevalence of SARS-CoV-2...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Med
Päätekijät: Cantini, Luca, Bastianelli, Lucia, Lupi, Alessio, Pinterpe, Giada, Pecci, Federica, Belletti, Giovanni, Stoico, Rosa, Vitarelli, Francesca, Moretti, Marco, Onori, Nicoletta, Giampieri, Riccardo, Rocchi, Marco Bruno Luigi, Berardi, Rossana
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038489/
https://ncbi.nlm.nih.gov/pubmed/33916569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071503
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia